Background Hemorrhagic transformation (HT) is a common complication of alteplase
treatment. However, the prevalence rate, risk factors, and clinical outcomes of remote …

Background and purpose Remote intracerebral hemorrhage (rICH) is infrequent after
intravenous thrombolysis (IVT) and its mechanism remains poorly understood. We aimed to …

Objective To test the hypothesis that remote intracerebral hemorrhages (r-ICHs) after IV
thrombolysis occur in preexisting brain lesions. Method We prospectively collected baseline …

Background and Purpose—Intracerebral hemorrhage after treatment with intravenous
recombinant tissue-type plasminogen activator for ischemic stroke can occur in local relation …

Background and purpose Remote parenchymal haemorrhage (rPH) after intravenous
thrombolysis is defined as hemorrhages that appear in brain regions without visible …

Background and Purpose—Remote parenchymal hemorrhage (rPH) after intravenous
thrombolysis with recombinant tissue-type plasminogen activator may be associated with …

Purpose—Symptomatic intracranial hemorrhage (sICH) is the most feared complication of
intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on …

Aim: Intracerebral hemorrhage (ICH) is one of the most severe complications of
thrombolysis. Symptomatic ICHs are associated with adverse outcomes. It has been …

Background Thrombolysis improves the outcome in acute ischemic stroke (AIS), albeit with
an increased risk of symptomatic intracranial hemorrhage (sICH). Biomarkers to find patients …

Importance Cerebral microbleeds (CMBs) have been established as an independent
predictor of cerebral bleeding. There are contradictory data regarding the potential …